J
Power Law company profile
Jazz Pharmaceuticals
Biotech & Life Sciences · Dublin, Ireland · Founded 2003 · IPO 2007 Decacorn
Valuation
$16B
Market cap · Apr/2026
Revenue
$4.27B
Latest reported FY
Global footprint
Where Jazz Pharmaceuticals has talent and traffic
AI talent share
0.5%
of workforce is AI talent
(19 of 3,627 staff)
(19 of 3,627 staff)
Core AI10.03%
Other AI180.5%
Non-AI workforce3,60899.48%
Web traffic by country
81K
monthly visits
across markets
across markets
🇺🇸 United States46.7%
🇬🇧 United Kingdom13.6%
🇮🇪 Ireland7.3%
🇮🇳 India5.9%
🏳️ Nigeria4.4%
Patent intelligence
$300M patent portfolio · 149 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$300M
1.9% of market cap · 1.8× the top peer Amicus Therapeutics ($164M)
149 active patent families
Where Jazz Pharmaceuticals innovates
PharmacologyMedicinal chemistryDrugCannabidiolCannabivarin
Above peer median on Legal, Strategic, Market, Technology
Quality vs same-sector peers
Jazz Pharmaceuticals on the five Patsnap quality dimensions
Jazz Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Jazz Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Jazz Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Jazz Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.